PHGE
BiomX Inc.Company Information
- Company Name
- BiomX Inc.
- CIK
- CIK0001739174
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- PHGE: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- PHGE
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-05-22
- Last sale
- 2026-03-17
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 900,000
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 698,441
- Shares outstanding
- 10,313,076
- Ownership
- 6.77%
Earnings Market Reaction
- Filing date
- 2026-08-19
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Private Placement | - | - | - | - | - | - | - | - | 25 | - | - | - | ||||||
| Related Party | 1 | - | - | - | - | - | - | - | - | - | - | - | ||||||
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 1 | 4 | 7 | 14 | 20 | 17 | 24 | 32 | 43 | 15 | 22 | ||||||
| Restricted Cash Current | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 2 | 3 | 6 | 9 | 17 | 24 | 21 | 28 | 35 | 47 | 18 | 25 | ||||||
| Short Term Investments | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Accounts Receivable Net Current | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Other Assets Current | 2 | 2 | 0 | 1 | 2 | 2 | 3 | 4 | 2 | 3 | 2 | 2 | ||||||
Non Current Assets | ||||||||||||||||||
| Other Assets Noncurrent | - | - | - | - | - | - | - | 0 | 0 | - | - | - | ||||||
| Restricted Cash Noncurrent | - | - | - | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
Assets Noncurrent | ||||||||||||||||||
| Assets Noncurrent | 26 | - | 0 | 17 | 21 | 22 | 23 | 32 | 34 | 35 | 7 | 8 | ||||||
| Property Plant And Equipment Net | 0 | - | - | 3 | 4 | 5 | 5 | 7 | 7 | 7 | 4 | 4 | ||||||
| Goodwill | - | - | - | - | - | - | - | - | 16 | 16 | - | - | ||||||
| Development In Process | - | - | - | - | - | - | - | 15 | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 0 | - | - | 2 | 5 | 5 | 5 | 10 | 10 | 11 | 3 | 4 | ||||||
| Assets | 28 | 3 | 6 | 26 | 38 | 46 | 43 | 60 | 69 | 82 | 25 | 33 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Short Term Borrowings | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Accounts Payable Trade Current | 1 | 1 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 4 | 1 | 1 | ||||||
| Long Term Debt And Capital Lease Obligations Current | - | - | - | - | - | - | - | - | - | - | - | 1 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 10 | 2 | 6 | 5 | 6 | 7 | 8 | 9 | 7 | 11 | 11 | 13 | ||||||
| Other Notes Payable Current | 1 | 1 | - | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 0 | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | ||||||
| Accounts Payable Other Current | 1 | 0 | 2 | 2 | 3 | 4 | 5 | 5 | 3 | 6 | 3 | 6 | ||||||
| Debt And Capital Lease Obligations | - | - | - | - | - | - | - | - | - | - | - | 6 | ||||||
| Long Term Debt Current | - | - | - | - | - | - | - | - | - | - | 6 | - | ||||||
Non Current Liabilities | ||||||||||||||||||
| Contract With Customer Liability Noncurrent | - | - | - | - | - | - | - | - | - | 2 | 2 | 2 | ||||||
| Long Term Debt Noncurrent | 0 | - | - | - | - | - | - | - | - | - | 5 | 7 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Liabilities Noncurrent | 0 | 2 | 1 | 10 | 13 | 14 | 11 | 13 | 34 | 48 | 11 | 12 | ||||||
| Operating Lease Liability Noncurrent | 0 | - | - | 5 | 8 | 8 | 8 | 9 | 9 | 9 | 3 | 3 | ||||||
| Other Liabilities Noncurrent | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Warrants And Rights Outstanding | 0 | 2 | 1 | 5 | 4 | 6 | 2 | 4 | 25 | - | - | - | ||||||
Redeemable Convertible Preferred Shares | ||||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | - | - | - | 32 | - | - | ||||||
| Liabilities | 11 | 4 | - | - | - | - | - | - | - | - | - | - | ||||||
| Preferred Stock Value | 7 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 32 | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock | -0 | -3 | - | - | - | - | - | - | - | - | - | - | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | 18 | -1 | -1 | 10 | 19 | 24 | 24 | 38 | 27 | -10 | 3 | 8 | ||||||
| Additional Paid In Capital | 244 | 220 | 197 | 195 | 195 | 194 | 186 | 185 | 171 | 171 | 166 | 166 | ||||||
| Retained Earnings Accumulated Deficit | -240 | -236 | -217 | -204 | -194 | -188 | -181 | -166 | -176 | -180 | -163 | -157 | ||||||
| Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax | -0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Minority Interest | 7 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities And Stockholders Equity | 28 | 3 | 6 | 26 | 38 | 46 | 43 | 60 | 69 | 82 | 25 | 33 | ||||||
| Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | 0.00 | - | - | ||||||
| Temporary Equity Shares Authorized | - | - | - | - | - | - | - | - | - | 1 | - | - | ||||||
| Temporary Equity Shares Issued | - | - | - | - | - | - | - | - | - | 0 | - | - | ||||||
| Temporary Equity Shares Outstanding | - | - | - | - | - | - | - | - | - | 0 | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | 1 | 1 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 750 | 120 | 120 | 120 | 120 | ||||||
| Common Stock Shares Issued | 13 | 7 | 2 | 27 | 26 | 25 | 1 | 18 | 7 | 6 | 5 | 5 | ||||||
| Shares Outstanding | 13 | 7 | 2 | 27 | 26 | 25 | 1 | 18 | 7 | 6 | 5 | 5 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBiomX Inc. (PHGE) — SEC Financial Statements & Analysis
BiomX Inc. (PHGE) is a biological products, (no diagnostic substances) company, incorporated in DE. BiomX Inc. trades on NYSE as: PHGE. BiomX Inc. (PHGE)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-19. Based on that filing, On profitability, BiomX Inc. posts an operating margin of 9935.84%, a net margin of 13701.51%, a Return on Equity (ROE) of 303.01%, a Return on Assets (ROA) of 137.35%, and a Return on Invested Capital (ROIC) of 441.09%. Per share, it reports EPS of $4.41, diluted EPS of $4.41, free cash flow per share of $-1.83, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 145.00% year-over-year and EPS growth of -60.85% year-over-year. On the balance sheet, it maintains a current ratio of 0.24x, a quick ratio of 0.24x, working capital of $-7.76M, a debt-to-equity ratio of 0.97x, a debt ratio of 0.37, an interest coverage ratio of 148.59x, free cash flow of $-18.91M (TTM), and net debt of $110.00K. Figures sourced from SEC EDGAR.
- EPS TTM
- $4.41
- ROE TTM
- 303.01%
- ROA TTM
- 137.35%
- Debt To Equity
- 0.97x
- Free Cash Flow TTM
- $-18.91M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BiomX Inc. in?
BiomX Inc. (PHGE) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does PHGE trade on?
BiomX Inc. (PHGE) trades on the NYSE.
Where is BiomX Inc. incorporated?
BiomX Inc. is incorporated in DE.
When was BiomX Inc. (PHGE)'s most recent SEC filing?
BiomX Inc. (PHGE)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-19.
What is PHGE's EPS (earnings per share)?
BiomX Inc. (PHGE)'s trailing twelve month EPS is $4.41 as of 2026-06-30.
What is PHGE's ROE (return on equity)?
BiomX Inc. (PHGE)'s trailing twelve month Return on Equity (ROE) is 303.01% as of 2026-06-30.
What is PHGE's ROA (return on assets)?
BiomX Inc. (PHGE)'s trailing twelve month Return on Assets (ROA) is 137.35% as of 2026-06-30.
What is PHGE's ROIC (return on invested capital)?
BiomX Inc. (PHGE)'s trailing twelve month Return on Invested Capital (ROIC) is 441.09% as of 2026-06-30.